Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Heinze
Rainer Oberbauer

Showing results (1-10 of 549) with videos related to

Pageof 55
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2007
Does size matter?Georg Heinze, Rainer Oberbauer
Transplant International : Official Journal of the European Society for Organ Transplantation|October 13, 2017
An unjustified benefit: immortal time bias in the analysis of time-dependent eventsAndreas Gleiss, Rainer Oberbauer, Georg Heinze
Transplant International : Official Journal of the European Society for Organ Transplantation|September 28, 2019
To test or to estimate? P-values versus effect sizesDaniela Dunkler, Maria Haller, Rainer Oberbauer, et al.
BMJ (Clinical Research Ed.)|October 27, 2009
Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort studyGeorg Heinze, Alexander Kainz, Walter H Hörl, et al.
Transplantation|November 10, 2009
Mycophenolate mofetil use is associated with prolonged graft survival after kidney transplantationAlexander Kainz, Georg Heinze, Réka Korbély, et al.
BMC Nephrology|March 18, 2014
Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the artJulie Boucquemont, Georg Heinze, Kitty J Jager, et al.
Contemporary Clinical Trials|January 4, 2020
Response to: "Biostatistics pitfalls: Lessons learned from analysis of medical data" by Yin et alRoman Reindl-Schwaighofer, Andreas Heinzel, Georg Heinze, et al.
Kidney International|December 17, 2003
Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantationChristoph Schwarz, Christa Mitterbauer, Georg Heinze, et al.
Journal of the American Society of Nephrology : JASN|July 25, 2008
Statin use is associated with prolonged survival of renal transplant recipientsFranz Wiesbauer, Georg Heinze, Christa Mitterbauer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2008
ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrationsChrista Mitterbauer, Georg Heinze, Alexander Kainz, et al.
Pageof 55

Showing results (1-10 of 549) with videos related to

Sort By:
Pageof 55
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2007
Does size matter?Georg Heinze, Rainer Oberbauer
Transplant International : Official Journal of the European Society for Organ Transplantation|October 13, 2017
An unjustified benefit: immortal time bias in the analysis of time-dependent eventsAndreas Gleiss, Rainer Oberbauer, Georg Heinze
Transplant International : Official Journal of the European Society for Organ Transplantation|September 28, 2019
To test or to estimate? P-values versus effect sizesDaniela Dunkler, Maria Haller, Rainer Oberbauer, et al.
BMJ (Clinical Research Ed.)|October 27, 2009
Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort studyGeorg Heinze, Alexander Kainz, Walter H Hörl, et al.
Transplantation|November 10, 2009
Mycophenolate mofetil use is associated with prolonged graft survival after kidney transplantationAlexander Kainz, Georg Heinze, Réka Korbély, et al.
BMC Nephrology|March 18, 2014
Regression methods for investigating risk factors of chronic kidney disease outcomes: the state of the artJulie Boucquemont, Georg Heinze, Kitty J Jager, et al.
Contemporary Clinical Trials|January 4, 2020
Response to: "Biostatistics pitfalls: Lessons learned from analysis of medical data" by Yin et alRoman Reindl-Schwaighofer, Andreas Heinzel, Georg Heinze, et al.
Kidney International|December 17, 2003
Nonsustained effect of short-term bisphosphonate therapy on bone turnover three years after renal transplantationChristoph Schwarz, Christa Mitterbauer, Georg Heinze, et al.
Journal of the American Society of Nephrology : JASN|July 25, 2008
Statin use is associated with prolonged survival of renal transplant recipientsFranz Wiesbauer, Georg Heinze, Christa Mitterbauer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2008
ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrationsChrista Mitterbauer, Georg Heinze, Alexander Kainz, et al.
Pageof 55